Cara Therapeutics
CARA
#10952
Rank
A$12.25 M
Marketcap
A$8.04
Share price
-2.56%
Change (1 day)
15.19%
Change (1 year)

EPS for Cara Therapeutics (CARA)

EPS in 2024 (TTM): A-$31.32

According to Cara Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$31.73. In 2023 the company made an earnings per share (EPS) of A-$39.52 a decrease over its 2022 EPS that were of A-$28.83.

EPS history for Cara Therapeutics from 2013 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$31.32-20.75%
2023A-$39.5237.11%
2022A-$28.83-8.09%
2021A-$31.36
2019A-$45.1420.87%
2018A-$37.357.85%
2017A-$34.63-9.05%
2016A-$38.07110%
2015A-$18.1317.65%
2014A-$15.41-3.42%
2013A-$15.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.09-131.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.07-103.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
A-$52.49 65.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A-$76.01 139.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
A-$3.37-89.38%๐Ÿ‡บ๐Ÿ‡ธ USA